Keri G - Search Results

1

Signaling through RAS-RAF-MEK-ERK: from basics to bedside.

Zebisch A, Czernilofsky AP, Keri G, Smigelskaite J, Sill H, Troppmair J. Zebisch A, et al. Among authors: keri g. Curr Med Chem. 2007;14(5):601-23. doi: 10.2174/092986707780059670. Curr Med Chem. 2007. PMID: 17346150 Review.

2

Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.

Zsila F, Fitos I, Bencze G, Kéri G, Orfi L. Zsila F, et al. Among authors: keri g. Curr Med Chem. 2009;16(16):1964-77. doi: 10.2174/092986709788682191. Curr Med Chem. 2009. PMID: 19519376 Review.

3

Plant-derived protein tyrosine kinase inhibitors as anticancer agents.

Hollósy F, Kéri G. Hollósy F, et al. Among authors: keri g. Curr Med Chem Anticancer Agents. 2004 Mar;4(2):173-97. doi: 10.2174/1568011043482124. Curr Med Chem Anticancer Agents. 2004. PMID: 15032721 Review.

4

Acid-base profiling of imatinib (gleevec) and its fragments.

Szakács Z, Béni S, Varga Z, Orfi L, Kéri G, Noszál B. Szakács Z, et al. Among authors: keri g. J Med Chem. 2005 Jan 13;48(1):249-55. doi: 10.1021/jm049546c. J Med Chem. 2005. PMID: 15634018

5

Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR.

Hegymegi-Barakonyi B, Eros D, Szántai-Kis C, Breza N, Bánhegyi P, Szabó GV, Várkondi E, Peták I, Orfi L, Kéri G. Hegymegi-Barakonyi B, et al. Among authors: keri g. Curr Opin Mol Ther. 2009 Jun;11(3):308-21. Curr Opin Mol Ther. 2009. PMID: 19479664

6

Small-molecule inhibitors of NADPH oxidase 4.

Borbély G, Szabadkai I, Horváth Z, Markó P, Varga Z, Breza N, Baska F, Vántus T, Huszár M, Geiszt M, Hunyady L, Buday L, Orfi L, Kéri G. Borbély G, et al. Among authors: keri g. J Med Chem. 2010 Sep 23;53(18):6758-62. doi: 10.1021/jm1004368. J Med Chem. 2010. PMID: 20731357

7

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.

Németh G, Greff Z, Sipos A, Varga Z, Székely R, Sebestyén M, Jászay Z, Béni S, Nemes Z, Pirat JL, Volle JN, Virieux D, Gyuris Á, Kelemenics K, Ay E, Minarovits J, Szathmary S, Kéri G, Orfi L. Németh G, et al. Among authors: keri g. J Med Chem. 2014 May 22;57(10):3939-65. doi: 10.1021/jm401742r. Epub 2014 May 2. J Med Chem. 2014. PMID: 24742150

8

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1.

Hegedus T, Orfi L, Seprodi A, Váradi A, Sarkadi B, Kéri G. Hegedus T, et al. Among authors: keri g. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):318-25. doi: 10.1016/s0925-4439(02)00095-9. Biochim Biophys Acta. 2002. PMID: 12084474 Free article. Review.

9

Comparison of predictive ability of water solubility QSPR models generated by MLR, PLS and ANN methods.

Erös D, Kéri G, Kövesdi I, Szántai-Kis C, Mészáros G, Orfi L. Erös D, et al. Among authors: keri g. Mini Rev Med Chem. 2004 Feb;4(2):167-77. doi: 10.2174/1389557043487466. Mini Rev Med Chem. 2004. PMID: 14965289

10

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.

Ozvegy-Laczka C, Hegedus T, Várady G, Ujhelly O, Schuetz JD, Váradi A, Kéri G, Orfi L, Német K, Sarkadi B. Ozvegy-Laczka C, et al. Among authors: keri g. Mol Pharmacol. 2004 Jun;65(6):1485-95. doi: 10.1124/mol.65.6.1485. Mol Pharmacol. 2004. PMID: 15155841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters